Georgetown University
Cota, MedStar Health Ink Real-World Data Research Partnership
Real-world data analytics firm Cota will provide MedStar's providers with curated longitudinal, deidentified datasets to inform precision oncology research.
Small Cell Lung Cancer Study Uncovers Disease-Associated Germline Mutations
The study, which showed that the disease may not only result from tobacco exposure as previously thought, could lay the groundwork for targeted therapies.
Lantern Pharma, Georgetown University Advance Prostate, Pancreatic Cancer Rx Candidate
The drug, LP-184, demonstrated increased efficacy against prostate cancer cells overexpressing PTGR1 in preclinical studies and inspired further research.
Informaticians from Georgetown and other major cancer centers expect their technology to bring precision oncology services to community hospitals and clinics.